ASTRO 2025 Conference Videos

LUNAR Trial: Neoadjuvant Lutetium-PSMA Plus SBRT Evaluated in Oligometastatic Prostate Cancer - Amar Kishan & Jeremie Calais

Rectal Spacer Use Leads to Better Patient-Reported Bowel and Sexual Outcomes - Daniel Song

Analysis of ctDNA After Trimodal Therapy for Muscle-Invasive Bladder Cancer - Dekuang Zhao

Patient-Reported Outcomes in the NRG-GU005 Prostate Cancer Trial - James Yu

Neoadjuvant Pembrolizumab and Radiotherapy for Kidney Cancer - Muhammad Ali

Ten-Year Outcomes of the PCS5 Trial for High-Risk Prostate Cancer Presented - Tamim Niazi

Adjuvant Radiotherapy Evaluated for High-Risk Bladder Cancer After Cystectomy - Vedang Murthy

Analysis of Genomic Drivers of Discordant Risk Classifications in Prostate Cancer - Michael Zelefsky

NRG-GU006 Trial for Post-Prostatectomy Radiation Therapy - Daniel Spratt

Phase 2 EXTEND Trial of Metastasis-Directed Therapy with Continuous Hormone Therapy - Alexander Sherry & Bilal Siddiqui

Validating the APUC-6 Signature in mHSPC from the ECOG-ACRIN E3805 CHAARTED Trial - Xiaolei Shi

NRG-GU005 Trial Compares SBRT and Hypofractionated IMRT for Prostate Cancer - Rodney Ellis

Phase II LUNAR Trial Results: Adding Lutetium PSMA to SBRT for Oligorecurrent Prostate Cancer - Amar Kishan